Rankings
▼
Calendar
▼
CNTB Q2 2020 Earnings Report — Connect Biopharma Holdings Limited Revenue & Financial Results | Market Cap Arena
Connect Biopharma Holdings Limited
CNTB
Q2 2020 Earnings
Reported June 29, 2020
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q2 2020
Q1 2020
Q2 2019
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$9.0K
—
—
—
—
EPS (Diluted)
$-0.00
—
—
—
—
Free Cash Flow
-$7.5K
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$8.4K
Selling & Marketing
$0
General & Administrative
$1.0K
SG&A Expenses
$1.0K
Other Expenses
$0
Operating Expenses
$10.8K
Cost & Expenses
$10.8K
OPERATING INCOME
-$9.0K
Interest Income
$133
Interest Expense
$0
Other Income/Expenses
-$2M
INCOME BEFORE TAX
-$10.6K
Income Tax Expense
$0
Net Income from Continuing Ops
-$11M
Net Income from Discontinued Ops
$0
Other Adjustments
$11M
NET INCOME
-$10.6K
Net Income Deductions
$11M
BOTTOM LINE NET INCOME
-$11M
D&A
$27
EBIT
-$9M
EBITDA
-$9M
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$10.6K
Depreciation & Amortization
$55
Stock-Based Compensation
$225
Deferred Income Tax
$0
Other Non-Cash Items
$4.0K
Change in Working Capital
-$1.1K
OPERATING CASH FLOW
-$7.5K
Capital Expenditure
-$48
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
$658
NET CASH FROM INVESTING
$610
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
-$31
NET CASH FROM FINANCING
-$31
FREE CASH FLOW
-$7.5K
Net Change in Cash
-$3.2K
marketcaparena.com
← FY 2020
CNTB Overview
Q4 2020 →